Family Office - Multi • Geneva, Switzerland

GSK & Partners

GSK & Partners is a family office - multi based in Geneva, Switzerland, founded in 2021. Verified contact details, AUM data, and investment preferences on FindLPs.

$900M
Assets Under Mgmt
2021
Year Founded
Family Office - Multi
Investor Type
Geneva, Switzerland
Headquarters
About

GSK & Partners

GSK & Partners is a Multi Family Office firm based in Geneva, Switzerland. Established in 2021, to help clients incorporate their values and financial goals into a clear strategy to enhance their wealth and simplify their life. GSK & Partner's investments are valued at $900 million as of June 20, 2024 with investments in private equity and alternative asset classes. Average down with existing Private Equity managers and sectors. Investments in private equity include buyouts, diversified private equity, private equity growth expansion, and venture capital fund strategies.

Investment Focus

What GSK & Partners Invests In

Investment types: Buyout, Private Equity, Growth/Expansion, Venture Capital, Venture Capital - Early Stage, Venture Capital - Later Stage

Preferred geographies: Europe, United States

Location: 61 Rue du Rhône\n1st floor\nGeneva, Switzerland\n1204\nSwitzerland

Contact GSK & Partners

FindLPs holds verified direct email addresses and phone numbers for decision-makers at GSK & Partners. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.

Unlock Contact Details

Find LPs like GSK & Partners

Search 25,850 limited partners with verified contact details.

LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.